Last 12 months
Inside the activity.
14 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 6 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 1 | 5 |
| Oct 2026 | 2 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2024 Filed Nov 27, 2025 02:55 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 16 | $0.84 | $13.44 |
DisclosureSEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 4 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,524,361 Read SEC document |
| March 05, 2024 Filed Nov 27, 2025 02:54 UTC |
Casaburi EricDirector
|
PurchaseCommon Stock | 2,000 | $0.74 | $1,480.00 |
DisclosureSEC source: 0001493152-25-025274 · ownership.xml · nonDerivative · entry 4 Casaburi Eric · CIK 0001990853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,575 Read SEC document |
| February 29, 2024 Filed Nov 27, 2025 02:54 UTC |
Casaburi EricDirector
|
PurchaseCommon Stock | 575 | $0.72 | $414.00 |
DisclosureSEC source: 0001493152-25-025274 · ownership.xml · nonDerivative · entry 3 Casaburi Eric · CIK 0001990853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,575 Read SEC document |
| February 16, 2024 Filed Nov 27, 2025 02:55 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 100 | $0.82 | $82.00 |
DisclosureSEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 3 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,524,345 Read SEC document |
| February 16, 2024 Filed Nov 27, 2025 02:54 UTC |
Casaburi EricDirector
|
PurchaseCommon Stock | 2,000 | $0.77 | $1,540.00 |
DisclosureSEC source: 0001493152-25-025274 · ownership.xml · nonDerivative · entry 2 Casaburi Eric · CIK 0001990853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,000 Read SEC document |
| February 08, 2024 Filed Nov 27, 2025 02:55 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 2 | $1.19 | $2.38 |
DisclosureSEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 2 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,524,245 Read SEC document |
| February 01, 2024 Filed Nov 27, 2025 02:55 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 1,357 | $1.45 | $1,967.65 |
DisclosureSEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 1 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,524,243 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.38 to $1.55, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in the footnotes of this report. Read SEC document |
| January 30, 2024 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 400 | $1.14 | $456.00 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 23 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,522,886 F14 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.03 to $1.48, inclusive. Read SEC document |
| January 29, 2024 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 950 | $1.04 | $988.00 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 22 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,522,486 F13 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.03 to $1.07, inclusive. Read SEC document |
| January 26, 2024 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 5,386 | $0.56 | $3,016.16 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 21 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,521,536 F12 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.51 to $0.60, inclusive. Read SEC document |
| January 25, 2024 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 2,304 | $0.55 | $1,267.20 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 20 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,516,150 F11 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.50 to $0.60, inclusive. Read SEC document |
| January 24, 2024 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 740 | $0.55 | $407.00 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 19 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,513,846 F10 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.52 to $0.60, inclusive. Read SEC document |
| January 23, 2024 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 720 | $0.52 | $374.40 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 18 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,513,106 F9 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.48 to $0.54, inclusive. Read SEC document |
| January 22, 2024 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 5,035 | $0.49 | $2,467.15 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 17 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,512,386 F8 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.44 to $0.62, inclusive. Read SEC document |
| January 19, 2024 Filed Nov 27, 2025 02:54 UTC |
Golden Robert LawrenceDirector · Chief Financial Officer
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-025275 · ownership.xml · nonDerivative · entry 2 Golden Robert Lawrence · CIK 0001585507 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,300 F1 · shares: Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vested on December 31, 2024. Read SEC document |
| January 19, 2024 Filed Nov 27, 2025 02:54 UTC |
Green AaronDirector · Chief Executive Officer
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-025276 · ownership.xml · nonDerivative · entry 1 Green Aaron · CIK 0001990275 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 645,000 F1 · shares: Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vested on December 31, 2024. Read SEC document |
| January 19, 2024 Filed Nov 27, 2025 02:54 UTC |
Kosasa ThomasDirector
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-025277 · ownership.xml · nonDerivative · entry 1 Kosasa Thomas · CIK 0001989846 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,378,824 F1 · shares: Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vested on December 31, 2024. Read SEC document |
| January 19, 2024 Filed Nov 27, 2025 02:54 UTC |
Casaburi EricDirector
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-025274 · ownership.xml · nonDerivative · entry 1 Casaburi Eric · CIK 0001990853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 F1 · shares: Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vested on December 31, 2024. Read SEC document |
| January 19, 2024 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 16 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,507,351 F15 · shares: Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vested on December 31, 2024. Read SEC document |
| January 19, 2024 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 60 | $0.48 | $28.80 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 15 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,462,351 F7 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.44 to $0.62, inclusive. Read SEC document |
| January 17, 2024 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 362 | $0.61 | $220.82 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 14 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,462,291 F6 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.56 to $0.73, inclusive. Read SEC document |
| January 16, 2024 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 15 | $0.75 | $11.25 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 13 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,461,929 F5 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.71 to $0.78, inclusive. Read SEC document |
| January 12, 2024 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 20 | $0.81 | $16.20 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 12 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,461,914 Read SEC document |
| January 10, 2024 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 20 | $0.85 | $17.00 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 11 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,461,894 Read SEC document |
| January 09, 2024 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 100 | $0.86 | $86.00 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 10 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,461,874 Read SEC document |
| January 08, 2024 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 10 | $0.83 | $8.30 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 9 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,461,774 Read SEC document |
| January 04, 2024 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 180 | $0.84 | $151.20 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 8 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,461,764 F4 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.82 to $0.85, inclusive. Read SEC document |
| January 02, 2024 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 20 | $0.82 | $16.40 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 7 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,461,584 Read SEC document |
| December 27, 2023 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 10 | $1.03 | $10.30 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 6 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,461,564 Read SEC document |
| December 15, 2023 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 10 | $0.92 | $9.20 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 5 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,461,554 Read SEC document |
| December 13, 2023 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 50 | $1.09 | $54.50 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 4 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,461,544 Read SEC document |
| December 12, 2023 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 3,040 | $1.06 | $3,222.40 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 3 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,461,494 F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.03 to $1.09, inclusive. Read SEC document |
| December 11, 2023 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 30 | $1.36 | $40.80 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 2 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,458,454 F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.35 to $1.37, inclusive. Read SEC document |
| December 08, 2023 Filed Nov 27, 2025 02:54 UTC |
Yu JeffreyDirector · Chief Medical Officer
|
PurchaseCommon Stock | 3,300 | $1.31 | $4,323.00 |
DisclosureSEC source: 0001493152-25-025269 · ownership.xml · nonDerivative · entry 1 Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,458,424 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.28 to $1.31, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in the footnotes of this report. Read SEC document |
| December 07, 2023 Filed Nov 27, 2025 02:54 UTC |
Golden Robert LawrenceDirector · Chief Financial Officer
|
PurchaseCommon Stock | 300 | $1.71 | $513.00 |
DisclosureSEC source: 0001493152-25-025275 · ownership.xml · nonDerivative · entry 1 Golden Robert Lawrence · CIK 0001585507 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300 Read SEC document |
| August 11, 2023 Filed Aug 21, 2023 22:18 UTC |
Owl Creek Asset Management, L.P.10% owner
ALTMAN JEFFREY A10% owner
|
OtherClass A Common Stock, par value $0.0001 per share | 465,000 | $11.13 | $5,175,450.00 |
DisclosureSEC source: 0000902664-23-004537 · ownership.xml · nonDerivative · entry 1 Owl Creek Asset Management, L.P. · CIK 0001313756 · 10% owner ALTMAN JEFFREY A · CIK 0001269751 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: The Reporting Persons elected to redeem 465,000 shares held by OCCOMF (as defined below) for cash. F2 · ownership.nature: The securities to which this filing relates are held directly by Owl Creek Credit Opportunities Master Fund, L.P. ("OCCOMF"), a Cayman Islands exempted limited partnership, to which Owl Creek Asset Management, L.P., a Delaware limited partnership (the "Investment Manager"), serves as investment manager. Jeffrey A. Altman ("Mr. Altman") is the managing member of the general partner of the Investment Manager. Each of the Investment Manager and Mr. Altman disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| January 12, 2023 Filed Jan 13, 2023 16:24 UTC |
Shaolin Capital Management LLC10% owner
|
SaleData Knights Acquisition Corp. | 100,000 | $10.48 | $1,048,000.00 |
DisclosureSEC source: 0001766806-23-000001 · primary_doc.xml · nonDerivative · entry 1 Shaolin Capital Management LLC · CIK 0001766806 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.